Pfizer is looking to dump at least half of the former HQ of Global Blood Therapeutics, the sickle cell disease drug maker it ...
Pfizer has moved its global creative duties from Interpublic Group’s FCB and IPG Health into Publicis, just 10 months after ...
Less than a year after divvying up its marketing work between two firms, Publicis Groupe and Interpublic Group, Pfizer is ...
The chief executive officers of AstraZeneca Plc and Pfizer Inc. pledged to support expansion of China’s biopharmaceutical ...
Astellas (OTCPK:ALPMF) announced Thursday that Chinese regulators agreed to review a request to expand the label of Padcev, ...
Pfizer is moving the majority of its creative brand duties from Interpublic Group of Cos. to Publicis Groupe. The move comes ...
The math is straightforward for how Pfizer could reach a market cap of $1 trillion over the next 11 or so years. Pfizer's ...
Pfizer enjoyed a cash windfall with the success of its Covid vaccine, and the company has been aggressively investing this ...
The suit also alleges the employee violated his noncompete agreement when he took a job at Pfizer that is similar to the one ...
Financial giants have made a conspicuous bullish move on Pfizer. Our analysis of options history for Pfizer PFE revealed 15 ...
While Pfizer has ended one of its two Phase III studies for inclacumab in sickle cell disease, the company is still eyeing an ...
Astellas Pharma Inc. (ALPMY) announced that China's National Medical Products Administration or NMPA has accepted the supplemental ...